The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Aldeyra Therapeutics Inc | COM | 01438T106 | 25,301,454 | 3,015,668 | SH | SOLE | 3,015,668 | 0 | 0 | |||
Altimmune Inc | COM NEW | 02155H200 | 613,739 | 173,864 | SH | SOLE | 173,864 | 0 | 0 | |||
Altria Group Inc | COM | 02209S103 | 1,028,310 | 22,700 | SH | SOLE | 22,700 | 0 | 0 | |||
Applied Therapeutics Inc | COM | 03828A101 | 4,416,000 | 3,450,000 | SH | SOLE | 3,459,000 | 0 | 0 | |||
Avadel Pharmaceuticals Plc | SPONSORED ADR | 05337M104 | 8,240,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | |||
HOOKIPA PHARMA | COM | 43906K100 | 4,855,298 | 5,517,385 | SH | SOLE | 5,517,385 | 0 | 0 | |||
Verona Pharma | SPONSORED ADS | 925050106 | 4,228,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | |||
Biohaven Pharmactl Hldg Co L | COM | G11196105 | 10,774,092 | 450,422 | SH | SOLE | 450,422 | 0 | 0 | |||
BioXcell | COM | 09075P105 | 199,800 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | |||
Booz Allen Hamilton HLDG COR | CL A | 099502106 | 1,450,800 | 13,000 | SH | SOLE | 13,000 | 0 | 0 | |||
CVS Health Corp | COM | 126650100 | 1,002,385 | 14,500 | SH | SOLE | 14,500 | 0 | 0 | |||
Entera Bio Ltd | SHS | M40527109 | 2,094,243 | 2,484,275 | SH | SOLE | 2,484,275 | 0 | 0 | |||
Orgenesis, Inc. | COM | 68619K105 | 882,285 | 634,738 | SH | SOLE | 634,738 | 0 | 0 | |||
Ocular Therapeutix Inc. | COM | 67576A100 | 1,032,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | |||
Ocular Therapeutix Inc. | COM | 67576A100 | 814,300 | 95,800 | SH | Call | SOLE | 95,800 | 0 | 0 | ||
Ocuphire Pharma Inc. | COM | 67577R102 | 434,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
Omega Therapeutics Inc. | COM | 68217N105 | 968,856 | 173,010 | SH | SOLE | 173,010 | 0 | 0 | |||
Thermo Fischer Scientific Inc | COM | 883556102 | 1,095,675 | 2,100 | SH | SOLE | 2,100 | 0 | 0 | |||
Visa | COM CL A | 92826C839 | 1,151,778 | 4,850 | SH | SOLE | 4,850 | 0 | 0 | |||
SEABRIDGE GOLD INC | COM | 811916105 | 964,000 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | |||
Silvercrest Metals Inc CAD | COM | 828363101 | 996,200 | 170,000 | SH | SOLE | 170,000 | 0 | 0 | |||
Global X Silver Miners ETF 37954Y848 | Global X Silver | 37954Y848 | 2,331,303 | 89,700 | SH | SOLE | 89,700 | 0 | 0 | |||
Vaneck Gold Miners ETF | Gold Miners ETF | 92189F106 | 2,765,603 | 91,850 | SH | SOLE | 91,850 | 0 | 0 | |||
Vaneck Junior Gold Miners ETF | Junior Hold Mine | 92189F791 | 1,895,329 | 53,150 | SH | SOLE | 53,150 | 0 | 0 | |||
OSISKO GOLD ROYALTIES LTD | COM | 68827L101 | 969,200 | 400,000 | SH | SOLE | 235,000 | 0 | 0 | |||
Franco Nev Corp CAD | COM | 351858105 | 998,200 | 7,000 | SH | SOLE | 7,000 | 0 | 0 | |||
Northrop Grumman Corp | COM | 666807102 | 986,807 | 2,165 | SH | SOLE | 2,165 | 0 | 0 |